2D2 vs NSIS-B: Side-by-Side Comparison
Compare SCAND.INV.GR.NAM.B DK 05 (2D2) and Novonesis (Novozymes) A/S (NSIS-B) side by side: market cap EUR 17.29M vs DKK 191.95B, P/E 19.8 vs 43.1. Financials, growth and model signals on Bullrun.
| Metric | 2D2 | NSIS-B |
|---|---|---|
| Company | SCAND.INV.GR.NAM.B DK 05 | Novonesis (Novozymes) A/S |
| Country / Exchange | Denmark · F | Denmark · CO |
| Sector | Basic Materials | Basic Materials |
| Industry | Lumber & Wood Production | Specialty Chemicals |
| Market cap | EUR 17.29M | DKK 191.95B |
| P/E ratio | 19.8 | 43.1 |
| Dividend yield | — | 1.57% |
| Valuation model | — | 7.3% overvalued |
| Revenue (FY2025) | EUR 0 | EUR 4.16B |
| Revenue growth YoY | — | +8.5% |
| Net income | EUR 6.90M | EUR 583.60M |
| Gross margin | — | 53.9% |
| Diluted EPS | 0.15 | 1.25 |